solid
[F-].FB(F)F.C1CC=CCCC=C1.C[C@H]2CC[C@H](C)[PH]23c4ccccc4[PH]5([C@@H](C)CC[C@@H]5C)[Rh+]3(C)C
1S/C18H28P2.C8H12.2CH3.BF3.FH.Rh/c1-13-9-10-14(2)19(13)17-7-5-6-8-18(17)20-15(3)11-12-16(20)4;1-2-4-6-8-7-5-3-1;;;2-1(3)4;;/h5-8,13-16H,9-12H2,1-4H3;1-2,7-8H,3-6H2;2*1H3;;1H;/q;;;;;;-1/p+1/b;2-1-,8-7-;;;;;/t13-,14-,15-,16-;;;;;;/m0....../s1
TVGPORVCUKHBTJ-SKAPDIIBSA-O
请输入批号搜索分析证书(COA)。
请输入批号搜索原产地证书(COO)。
Asymmetric hydrogenation reactions represent the ideal process for the commercial manufacture of single-enantiomer compounds, because of the ease by which these robust procedures can be scaled up and because of the low levels of byproducts generated in these asymmetric hydrogenations.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门